C07D 277/12
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D277/12 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 515 US grants and 310 published applications in this corpus.
Search patents in C07D- Granted patents
- 515
- Published applications
- 310
- Assignees
- 274
- Inventors
- 1,347
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 13 | 0 |
| 1978 | 17 | 0 |
| 1979 | 10 | 0 |
| 1980 | 6 | 0 |
| 1981 | 13 | 0 |
| 1982 | 9 | 0 |
| 1983 | 14 | 0 |
| 1984 | 14 | 0 |
| 1985 | 10 | 0 |
| 1986 | 11 | 0 |
| 1987 | 8 | 0 |
| 1988 | 12 | 0 |
| 1989 | 12 | 0 |
| 1990 | 14 | 0 |
| 1991 | 12 | 0 |
| 1992 | 8 | 0 |
| 1993 | 14 | 0 |
| 1994 | 9 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 8 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 13 | 0 |
| 2001 | 11 | 1 |
| 2002 | 14 | 13 |
| 2003 | 12 | 29 |
| 2004 | 12 | 20 |
| 2005 | 16 | 22 |
| 2006 | 9 | 20 |
| 2007 | 12 | 14 |
| 2008 | 11 | 19 |
| 2009 | 8 | 13 |
| 2010 | 13 | 24 |
| 2011 | 8 | 10 |
| 2012 | 17 | 15 |
| 2013 | 10 | 14 |
| 2014 | 17 | 10 |
| 2015 | 9 | 10 |
| 2016 | 5 | 8 |
| 2017 | 10 | 13 |
| 2018 | 9 | 8 |
| 2019 | 8 | 4 |
| 2020 | 6 | 9 |
| 2021 | 3 | 6 |
| 2022 | 1 | 5 |
| 2023 | 5 | 8 |
| 2024 | 2 | 9 |
| 2025 | 4 | 2 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound as PPAR agonist and application thereof10 Feb 2026US 12,545,653 B2USA Elixiria Biotech Inc.
- Nitrosation reagents and methods4 Nov 2025US 12,459,909 B2The Regents of the University of California
- Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor12 Aug 2025US 12,383,535 B2China Pharmaceutical University
- Reduction of the odor of monothiocarbonate compounds by addition of oxidants8 Jul 2025US 12,351,563 B2BASF SE
- 2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use11 Mar 2025US 12,247,004 B2Oxford Drug Design Limited
- Modulation of global regulatory mechanisms and biosynthetic gene clusters for simplified production of natural products1 Oct 2026US 2026/0297627 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Ferroptosis inducers to treat cancer16 Jul 2026US 2026/0199297 A1The University of Toledo
- Synthetic cannabinoid analogs, pharmaceutical compositions, and methods of treating bacterial infections and other disorders7 May 2026US 2026/0125335 A1Miralogx LLC
- Nitrosation Reagents and Methods9 Apr 2026US 2026/0098021 A1
- Small molecule inhibitors of bacterial toxins16 Oct 2025US 2025/0320181 A1
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Photolabile compounds and methods for their use151US 5,739,386 AAffymax Technologies N.V. · 1998
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Cyclic imide thione activated polyalkylene oxides79US 5,405,877 AEnzon, Inc. · 1995
- Cyclic imide thione activated polyalkylene oxides76US 5,349,001 AEnzon, Inc. · 1994